Department of Pharmacy, National University of Singapore, Blk S4A Level 3, 18 Science Drive 4, Singapore, 117543, Singapore.
Department of Pharmacy, National Cancer Centre Singapore, Singapore, Singapore.
Support Care Cancer. 2018 Sep;26(9):3257-3266. doi: 10.1007/s00520-018-4189-y. Epub 2018 Apr 11.
Since few studies have investigated whether the Distress Thermometer (DT) in Asian adolescent and young adult (AYA) cancer patients (between 15 and 39 years), we investigated the appropriateness of the DT as a screening tool for psychological symptom burden in these AYA patients and to evaluate AYA patients' distress across a trajectory of three time points longitudinally over a 6-month period.
This was a prospective, longitudinal study. Recruited Asian AYA patients were diagnosed with lymphomas, sarcomas, primary brain malignancies, or germ cell tumors. Patients completed the DT, PedsQL Generic Core Scales, and the Rotterdam Symptom Checklist. Data were analyzed using STATA version 15.
Approximately half of the patients experienced clinically significant DT distress (distress score ≥ 4) early in their cancer journey with 43.1% patients presenting with distress at time of diagnosis and 47.7% patients 1 month after diagnosis. Among AYA patients > 24 years old, worry (68.3%), insurance/financial issues (61%), treatment decisions (43.9%), work/school issues (41.5%), nervousness (41.5%), and sadness (41.5%) were the top five identified problems. On the other hand, the top five identified problems among AYA ≤ 24 years were worry (54.2%), nervousness (41.7%), bathing/dressing problems (37.5%), work/school issues (33.3%), and fatigue (33.3%). DT scores were significantly associated with certain psychological symptom burden items such as worry (p < 0.001), depressed mood (p = 0.020), and nervousness (p = 0.015).
The DT is a useful screening tool for psychological distress in AYA cancer patients with clinically significant distress being identified in the early phases of the cancer journey.
由于很少有研究调查过 distress thermometer(DT)在亚洲青少年和年轻成人(AYA)癌症患者(15 至 39 岁)中的适用性,因此我们调查了 DT 是否适合作为这些 AYA 患者心理症状负担的筛查工具,并评估了 AYA 患者在 6 个月的时间内,经过三个时间点的纵向追踪,其痛苦程度。
这是一项前瞻性的纵向研究。招募的亚洲 AYA 患者被诊断患有淋巴瘤、肉瘤、原发性脑恶性肿瘤或生殖细胞瘤。患者完成了 DT、PedsQL 通用核心量表和 Rotterdam 症状清单。使用 STATA 版本 15 进行数据分析。
大约一半的患者在癌症早期就经历了临床显著的 DT 痛苦(痛苦评分≥4),43.1%的患者在诊断时出现痛苦,47.7%的患者在诊断后 1 个月出现痛苦。在年龄大于 24 岁的 AYA 患者中,担忧(68.3%)、保险/财务问题(61%)、治疗决策(43.9%)、工作/学校问题(41.5%)、紧张(41.5%)和悲伤(41.5%)是前五个确定的问题。另一方面,年龄≤24 岁的 AYA 患者前五个确定的问题是担忧(54.2%)、紧张(41.7%)、洗澡/穿衣问题(37.5%)、工作/学校问题(33.3%)和疲劳(33.3%)。DT 评分与某些心理症状负担项目显著相关,如担忧(p<0.001)、抑郁情绪(p=0.020)和紧张(p=0.015)。
DT 是一种用于评估 AYA 癌症患者心理痛苦的有效筛查工具,在癌症早期阶段就能发现具有临床意义的痛苦。